| # | Title | Journal | Year | Citations |
|---|
| 1 | Triggers, targets and treatments for thrombosis | Nature | 2008 | 932 |
| 2 | Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma | Blood | 2007 | 669 |
| 3 | Brain metastases | Nature Reviews Disease Primers | 2019 | 579 |
| 4 | Tumor-derived tissue factor–positive microparticles and venous thrombosis in cancer patients | Blood | 2013 | 271 |
| 5 | What is triple-negative breast cancer? | European Journal of Cancer | 2008 | 270 |
| 6 | Tissue factor–positive neutrophils bind to injured endothelial wall and initiate thrombus formation | Blood | 2012 | 254 |
| 7 | A Cell-Based Model of Thrombin Generation | Seminars in Thrombosis and Hemostasis | 2006 | 195 |
| 8 | Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse | Breast Cancer Research and Treatment | 2012 | 189 |
| 9 | β‐Thalassaemia and sickle cell anaemia as paradigms of hypercoagulability | British Journal of Haematology | 2007 | 188 |
| 10 | American Joint Committee on Cancer Tumor–Node–Metastasis Stage After Neoadjuvant Chemotherapy and Breast Cancer Outcome | Journal of the National Cancer Institute | 2005 | 185 |
| 11 | In vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps | Blood | 2017 | 183 |
| 12 | Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans | Blood | 2014 | 179 |
| 13 | Homogeneous low-molecular-weight heparins with reversible anticoagulant activity | Nature Chemical Biology | 2014 | 173 |
| 14 | Safety profile of recombinant factor VIIa | Seminars in Hematology | 2004 | 170 |
| 15 | Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741 | Annals of Oncology | 2005 | 145 |
| 16 | Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer | British Journal of Cancer | 2009 | 137 |
| 17 | Secondary solid cancer screening following hematopoietic cell transplantation | Bone Marrow Transplantation | 2015 | 136 |
| 18 | Tissue factor–positive tumor microvesicles activate platelets and enhance thrombosis in mice | Journal of Thrombosis and Haemostasis | 2016 | 128 |
| 19 | Trends in stage‐specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006 | Cancer | 2014 | 127 |
| 20 | The septic milieu triggers expression of spliced tissue factor mRNA in human platelets | Journal of Thrombosis and Haemostasis | 2011 | 119 |
| 21 | The polyphosphate–factor XII pathway drives coagulation in prostate cancer-associated thrombosis | Blood | 2015 | 117 |
| 22 | Clopidogrel-Associated TTP | Stroke | 2004 | 113 |
| 23 | Prospective study of sickle cell trait and venous thromboembolism incidence | Journal of Thrombosis and Haemostasis | 2015 | 113 |
| 24 | Breast Cancer Molecular Subtypes in Patients With Locally Advanced Disease: Impact on Prognosis, Patterns of Recurrence, and Response to Therapy | Seminars in Radiation Oncology | 2009 | 103 |
| 25 | Role of Tissue Factor in Venous Thrombosis | Annual Review of Physiology | 2011 | 103 |
| 26 | Antifibrinolytic Therapy and Perioperative Considerations | Anesthesiology | 2018 | 103 |
| 27 | Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease | Blood | 2015 | 101 |
| 28 | The glomerulopathy of sickle cell disease | American Journal of Hematology | 2014 | 100 |
| 29 | Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma | European Journal of Cancer | 2014 | 99 |
| 30 | Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and Europe | Haematologica | 2017 | 97 |
| 31 | Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5-dependent manner | Blood | 2016 | 95 |
| 32 | Tissue Factor and Its Measurement in Whole Blood, Plasma, and Microparticles | Seminars in Thrombosis and Hemostasis | 2010 | 94 |
| 33 | Erythropoietin Stimulates Tumor Growth via EphB4 | Cancer Cell | 2015 | 94 |
| 34 | Increased BCR responsiveness in B cells from patients with chronic GVHD | Blood | 2014 | 86 |
| 35 | Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies | Annals of Translational Medicine | 2018 | 86 |
| 36 | Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B | Blood Advances | 2019 | 85 |
| 37 | Synthetic oligosaccharides can replace animal-sourced low–molecular weight heparins | Science Translational Medicine | 2017 | 82 |
| 38 | How I treat patients with inherited bleeding disorders who need anticoagulant therapy | Blood | 2016 | 80 |
| 39 | Novel Oral Anticoagulants | Anesthesiology | 2010 | 80 |
| 40 | Improved survival after acute graft- versus -host disease diagnosis in the modern era | Haematologica | 2017 | 79 |
| 41 | Study EV-103: Preliminary durability results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma. | Journal of Clinical Oncology | 2020 | 79 |
| 42 | NF-κB Transcription Factor p50 Critically Regulates Tissue Factor in Deep Vein Thrombosis | Journal of Biological Chemistry | 2009 | 78 |
| 43 | Racial Differences in Advanced Colorectal Cancer Outcomes and Pharmacogenetics: A Subgroup Analysis of a Large Randomized Clinical Trial | Journal of Clinical Oncology | 2009 | 74 |
| 44 | A potent oral P‐selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease | American Journal of Hematology | 2012 | 72 |
| 45 | Birth Outcomes Among Adolescent and Young Adult Cancer Survivors | JAMA Oncology | 2017 | 68 |
| 46 | Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma: Guidelines from the American Society for Blood and Marrow Transplantation | Biology of Blood and Marrow Transplantation | 2015 | 65 |
| 47 | Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort | European Journal of Cancer | 2019 | 64 |
| 48 | Protease-Activated Receptor-2 Regulates the Innate Immune Response to Viral Infection in a Coxsackievirus B3–Induced Myocarditis | Journal of the American College of Cardiology | 2013 | 61 |
| 49 | Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT | Bone Marrow Transplantation | 2017 | 61 |
| 50 | Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma | Blood | 2013 | 60 |
